Locations:
Abu Dhabi|Canada|Florida|London|Nevada|Ohio|
Gray gradientGray gradient
Cleveland Clinic icon
Consult QD logo
Search IconSearch

Tag: peripheral artery disease (PAD)

alignment of crossing device in an endovascular procedure

Percutaneous Arterial Bypass for Long Fem-Pop Lesions: Uses Expand as Experience Mounts

Early learnings on use of the minimally invasive alternative to surgical bypass

illustration of femoropopliteal bypass with the DETOUR system

Pooled 2-Year Outcomes of DETOUR Trials Support Percutaneous Transfemoral Arterial Bypass

Larger data set confirms safety, efficacy and durability for SFA lesions over 20 cm

21-HVI-2541215 femoropopliteal-peripheral-artery-disease_650x450

Safety of Paclitaxel-Coated Balloon for PAD Confirmed Through Four Years of Follow-Up

Patient-level meta-analysis of ILLUMENATE trials finds no increased mortality with Stellarex DCB

20-HVI-1862825-CQD-Paclitaxel-coated-devices-for-PAD

Paclitaxel-Coated Devices for PAD: Mortality Signal Shrinks in Patient-Level Meta-Analysis

Risk attenuates as recovered data are added

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

19-HRT-201-PAD-650×450

Paclitaxel-Coated Devices for PAD: The View from the Vascular Leaders Forum

An expert recap of a fast-moving clinical controversy

18-HRT-116-USPSTF-Persp-CQD-Feat-2

USPSTF Is Missing the Mark on the Ankle-Brachial Index in PAD Screening. Here’s Why.

Dr. Heather Gornik takes issue with new draft recommendation

Two people exercising in gym

CMS Decision on Exercise Therapy for PAD: A Clear Win for Patients

Better results with fewer procedures anticipated

BackPage 1 of 1Next

Advertisement

Ad